Recombinant Human MCP-2 (CCL8)|重組人趨化蛋白-2/CCL8
產(chǎn)品名稱: Recombinant Human MCP-2 (CCL8)|重組人趨化蛋白-2/CCL8
產(chǎn)品型號(hào): C22-204-08
產(chǎn)品展商: PERFEMIKER
產(chǎn)品文檔: 無相關(guān)文檔
簡(jiǎn)單介紹
Recombinant Human MCP-2 (CCL8)|重組人趨化蛋白-2/CCL8 現(xiàn)貨促銷，>96% by SDS-PAGE and HPLC analyses.
Recombinant Human MCP-2 (CCL8)|重組人趨化蛋白-2/CCL8
的詳細(xì)介紹
產(chǎn)品名稱：Recombinant Human MCP-2 (CCL8)|重組人趨化蛋白-2/CCL8
單 位：支
Recombinant Human MCP-2 (CCL8)|重組人趨化蛋白-2/CCL8，國(guó)產(chǎn)細(xì)胞因子,cytokine
產(chǎn)品詳細(xì)介紹：
C22-204-08 2μg/￥500 10μg/￥1000 1mg/詢價(jià)
Purity:
>96% by SDS-PAGE and HPLC analyses.
Biological Activity:
Fully biologically active when compared to standard. Measured by its ability to chemoattract THP-1 human acute monocytic leukemia cells.The ED50 for this effect is typically 0.03-0.1μg/mL.
Storage:
This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
